Drug information provided by: Merative, Micromedex®
Bosutinib is used to treat chronic phase (CP) Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) in patients who are newly-diagnosed or who have taken other medicines that did not work well. This medicine is also used to treat accelerated phase (AP) or blast phase (BP) Ph+ CML in patients who have taken other medicines but did not work well. Leukemia is a type of cancer where the body makes abnormal white blood cells.
Bosutinib is an antineoplastic (cancer) medicine. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of normal cells may also be affected by bosutinib, other side effects can occur. Before you begin treatment, talk to your doctor about the benefits of this medicine as well as the possible risks of using it.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: Sept. 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.